United States Induced Pluripotent Stem Cells (iPSCs) Market Report & Forecast 2021-2027

United States Induced Pluripotent Stem Cells (iPSCs) Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Induced Pluripotent Stem Cells (iPSCs) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Induced Pluripotent Stem Cells (iPSCs) Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Induced Pluripotent Stem Cells (iPSCs) Overall Market Size
2.1 United States Induced Pluripotent Stem Cells (iPSCs) Market Size: 2021 VS 2027
2.2 United States Induced Pluripotent Stem Cells (iPSCs) Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Induced Pluripotent Stem Cells (iPSCs) Players in United States Market
3.2 Top United States Induced Pluripotent Stem Cells (iPSCs) Companies Ranked by Revenue
3.3 United States Induced Pluripotent Stem Cells (iPSCs) Revenue by Companies
3.4 Top 3 and Top 5 Induced Pluripotent Stem Cells (iPSCs) Companies in United States Market, by Revenue in 2020
3.5 Companies Induced Pluripotent Stem Cells (iPSCs) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Induced Pluripotent Stem Cells (iPSCs) Players in United States Market
3.6.1 List of Tier 1 Induced Pluripotent Stem Cells (iPSCs) Companies in United States
3.6.2 List of Tier 2 and Tier 3 Induced Pluripotent Stem Cells (iPSCs) Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Induced Pluripotent Stem Cells (iPSCs) Market Size Markets, 2021 & 2027
4.1.2 Human iPSCs
4.1.3 Mouse iPSCs
4.2 By Type - United States Induced Pluripotent Stem Cells (iPSCs) Revenue & Forecasts
4.2.1 By Type - United States Induced Pluripotent Stem Cells (iPSCs) Revenue, 2016-2021
4.2.2 By Type - United States Induced Pluripotent Stem Cells (iPSCs) Revenue, 2022-2027
4.2.3 By Type - United States Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Induced Pluripotent Stem Cells (iPSCs) Market Size, 2021 & 2027
5.1.2 Academic Research
5.1.3 Drug Development and Discovery
5.1.4 Toxicity Screening
5.1.5 Regenerative Medicine
5.1.6 Others
5.2 By Application - United States Induced Pluripotent Stem Cells (iPSCs) Revenue & Forecasts
5.2.1 By Application - United States Induced Pluripotent Stem Cells (iPSCs) Revenue, 2016-2021
5.2.2 By Application - United States Induced Pluripotent Stem Cells (iPSCs) Revenue, 2022-2027
5.2.3 By Application - United States Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2016-2027
6 Induced Pluripotent Stem Cells (iPSCs) Companies Profiles
6.1 Fujifilm Holding Corporation (CDI)
6.1.1 Fujifilm Holding Corporation (CDI) Company Details
6.1.2 Fujifilm Holding Corporation (CDI) Business Overview
6.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Introduction
6.1.4 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021)
6.1.5 Fujifilm Holding Corporation (CDI) Recent Developments
6.2 Ncardia
6.2.1 Ncardia Company Details
6.2.2 Ncardia Business Overview
6.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Introduction
6.2.4 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021)
6.2.5 Ncardia Recent Developments
6.3 Sumitomo Dainippon Pharma
6.3.1 Sumitomo Dainippon Pharma Company Details
6.3.2 Sumitomo Dainippon Pharma Business Overview
6.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Introduction
6.3.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021)
6.3.5 Sumitomo Dainippon Pharma Recent Developments
6.4 Astellas Pharma Inc
6.4.1 Astellas Pharma Inc Company Details
6.4.2 Astellas Pharma Inc Business Overview
6.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Introduction
6.4.4 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021)
6.4.5 Astellas Pharma Inc Recent Developments
6.5 Fate Therapeutics, Inc
6.5.1 Fate Therapeutics, Inc Company Details
6.5.2 Fate Therapeutics, Inc Business Overview
6.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Introduction
6.5.4 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021)
6.5.5 Fate Therapeutics, Inc Recent Developments
6.6 Pluricell Biotech
6.6.1 Pluricell Biotech Company Details
6.6.2 Pluricell Biotech Business Overview
6.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Introduction
6.6.4 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021)
6.6.5 Pluricell Biotech Recent Developments
6.7 Cell Inspire Biotechnology
6.7.1 Cell Inspire Biotechnology Company Details
6.7.2 Cell Inspire Biotechnology Business Overview
6.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Introduction
6.7.4 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021)
6.7.5 Cell Inspire Biotechnology Recent Developments
6.8 ReproCELL
6.8.1 ReproCELL Company Details
6.8.2 ReproCELL Business Overview
6.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Introduction
6.8.4 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021)
6.8.5 ReproCELL Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Induced Pluripotent Stem Cells (iPSCs) Market Opportunities & Trends in United States Market
Table 2. Induced Pluripotent Stem Cells (iPSCs) Market Drivers in United States Market
Table 3. Induced Pluripotent Stem Cells (iPSCs) Market Restraints in United States Market
Table 4. Key Players of Induced Pluripotent Stem Cells (iPSCs) in United States Market
Table 5. Top Induced Pluripotent Stem Cells (iPSCs) Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Induced Pluripotent Stem Cells (iPSCs) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Companies, 2016-2021
Table 8. Companies Induced Pluripotent Stem Cells (iPSCs) Product Type
Table 9. List of Tier 1 Induced Pluripotent Stem Cells (iPSCs) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Induced Pluripotent Stem Cells (iPSCs) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn), 2022-2027
Table 17. Fujifilm Holding Corporation (CDI) Company Details
Table 18. Fujifilm Holding Corporation (CDI) Business Overview
Table 19. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product
Table 20. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Fujifilm Holding Corporation (CDI) Recent Developments
Table 22. Ncardia Company Details
Table 23. Ncardia Business Overview
Table 24. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product
Table 25. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Ncardia Recent Developments
Table 27. Sumitomo Dainippon Pharma Company Details
Table 28. Sumitomo Dainippon Pharma Business Overview
Table 29. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product
Table 30. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Sumitomo Dainippon Pharma Recent Developments
Table 32. Astellas Pharma Inc Company Details
Table 33. Astellas Pharma Inc Business Overview
Table 34. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product
Table 35. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Astellas Pharma Inc Recent Developments
Table 37. Fate Therapeutics, Inc Company Details
Table 38. Fate Therapeutics, Inc Business Overview
Table 39. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product
Table 40. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Fate Therapeutics, Inc Recent Developments
Table 42. Pluricell Biotech Company Details
Table 43. Pluricell Biotech Business Overview
Table 44. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product
Table 45. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Pluricell Biotech Recent Developments
Table 47. Cell Inspire Biotechnology Company Details
Table 48. Cell Inspire Biotechnology Business Overview
Table 49. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product
Table 50. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Cell Inspire Biotechnology Recent Developments
Table 52. ReproCELL Company Details
Table 53. ReproCELL Business Overview
Table 54. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product
Table 55. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. ReproCELL Recent Developments
List of Figures
Figure 1. Induced Pluripotent Stem Cells (iPSCs) Segment by Type
Figure 2. Induced Pluripotent Stem Cells (iPSCs) Segment by Application
Figure 3. United States Induced Pluripotent Stem Cells (iPSCs) Market Overview: 2020
Figure 4. United States Induced Pluripotent Stem Cells (iPSCs) Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Induced Pluripotent Stem Cells (iPSCs) Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2020
Figure 7. By Type - United States Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2016-2027
Figure 8. By Application - United States Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2016-2027
Figure 9. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs